Back
Denali Therapeutics, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
45
DNLI
Denali Therapeutics, Inc.
Last Price:
$16.86
Seasonality Move:
-13.05%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$35.06
Seasonality Move:
-22.7%
Sell
45
Denali Therapeutics, Inc. (DNLI)
is a Sell
Is Denali Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Denali Therapeutics, Inc. [DNLI] share price is $16.87. The Score for DNLI is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DNLI Stock Price Chart
What is Denali Therapeutics, Inc.'s stock price today?
-
The Denali Therapeutics, Inc. share price today is $16.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $35.09The current trend is moderately bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 44.75 | Sell |
| Chaikin Money Flow: | 463892 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.96 - 19.22) | Sell |
| Bollinger Bands (100): | (14.22 - 17.66) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.23 | Buy |
| Relative Strength Index (14 RSI): | 66.16 | Buy |
| Chaikin Money Flow: | -92149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.48 - 34.66) | Buy |
| Bollinger Bands (100): | (10.81 - 25.25) | Buy |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.95 | Sell |
| 20-day SMA: | 17.99 | Sell |
| 50-day SMA: | 17.23 | Sell |
| 200-day SMA: | 15.06 | Buy |
| 8-day EMA: | 17.12 | Sell |
| 20-day EMA: | 17.49 | Sell |
| 50-day EMA: | 17.11 | Sell |
| 200-day EMA: | 16.66 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.85 | Buy |
| 20-day SMA: | 30.4 | Buy |
| 50-day SMA: | 22.87 | Buy |
| 200-day SMA: | 13.87 | Buy |
| 8-day EMA: | 35.03 | Buy |
| 20-day EMA: | 31.05 | Buy |
| 50-day EMA: | 24.98 | Buy |
| 200-day EMA: | 18 | Buy |
Denali Therapeutics, Inc. Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and an increase next year of $0.04 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Denali Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||